General Medical Information

Cancer Chemotherapy & Biotherapy: Principles and Practice

Bruce A. Chabner, M.D.
Dan L. Longo, M.D.

1. Clinical Strategies for Cancer Treatment: The Role of Drugs
Dwight C. Kaufman and Bruce A. Chabner
2. Preclinical Aspects of Cancer Drug Discovery and Development
Jill L. Johnson, Anne Monks, Melinda G. Hollingshead, and Edward A. Sausville
3. Pharmacokinetics and Clinical Monitoring
Jerry M. Collins
4. Infertility after Cancer Chemotherapy
Richard L. Schilsky
5. Carcinogenesis: A Late Complication of Cancer Chemotherapy
Charles Erlichman and Malcolm Moore
6. Steroid Hormone Therapies for Cancer
Matthew J. Ellis and Sandra M. Swain
7. Antifolates
Richard A. Messmann and Carmen J. Allegra
8. 5-Fluoropyrimidines
Jean L. Grem
9. Cytidine Analogs
Rocio Garcia-Carbonero, David P. Ryan, and Bruce A. Chabner
10. Purine Antimetabolites
Kenneth R. Hande
11. Hydroxyurea
Luis Paz-Ares and Ross C. Donehower
12. Antimicrotubule Agents
Erk K. Rowinsky and Ross C. Donchower
13. Alkylating Agents
Kenneth D. Tew, O. Michael Colvin, and Bruce A. Chabner
14. Nonclassic Alkylating Agents
Henry S. Friedman, Steven D. Averbuch, and Joanne Kurtzberg
15. Cisplatin and Analogs
Eddie Reed
16. Bleomycin
John S. Lazo and Bruce A. Chabner
17. Antitumor Antibiotics
Jaap Verweij, Alex Sparreboom, and Kees Nooter
18. Anthracyclines and Anthracenediones
James H. Doroshow
19. Topoisomerase II Inhibitors: Epipodophyllotoxins, Acridines, Ellipticines, and Bisdioxopiperazines
Yves G. Pommier, François Goldwasser, and Dirk Strumberg
20. Topoisomerase I Targeting Agents: The Camptothecins
Chris H. Takimoto and Susan G. Arbuck
21. Enzyme Therapy: L-Asparaginase
Bruce A. Chabner and Stephen E. Sallan
22. Pharmacologic Considerations in Chemotherapy for Brain Tumors
Tracy T. Batchelor, Michel P. Gatineau, and Jeffrey G. Supko
23. Retinoids and Other Differentiating Agents
Joseph A. Fontana and Arun K. Rishi
24. Bisphosphonates
Matthew R. Smith
25. Radiation Modifiers
C. Norman Coleman and James B. Mitchell
26. Pharmacology of Interferons: Induced Proteins, Celi Activation, and Antitumor Activity
Dehorah J. Vestal, Taolin Yi, and Ernest C. Borden
27. Clinical Pharmacokinetics of Interleukin 1, Interleukin 2, Interleukin 4, Tumor Necrosis Factor, Interleukin 12, and Macrophage Colony-Stimulating Factor
Ronald M. Bukowski, Charles S. Tannenbaum, and James H. Finke
28. Colony-Stimulating Factors
William P. Petros
29. Antibody-Based Immunotherapies for Cancer
David A. Scheinberg, George Sgouros, and Richard P. Junghans
30. Targeted Therapy
Jeffrey W. Clark
31. Physical Barriers to Drug Delivery
Brendan D. Curti
32. Adoptive Cellular Therapy
Carl H. June
33. Cancer Vaccines 2001
Glenn Dranoff
34. Cytokine and Growth Factor and Receptor Database: Biologic, Molecular, and Pathophysiologic Properties of Ligand-Receptor Interactions
Eric Schaffer and Dennis D. Taub
35. Inhibitors of Tumor Angiogenesis
Ann L. Mellott and William J. Gradishar
36. Pharmacogenetics
Robert B. Diasio
37. Chemokine-Chemokine Receptor Database 2001: Biologic, Molecular, and Pathophysiologic Properties of Chemokine-Receptor Interactions
Harry D Dawson and Dennis D. Taub